Do you want to publish a course? Click here

Our study aimed to evaluating significance of survivin as a prognostic marker of relapse in children with acute lymphoblastic leukemia. The study included 46 child (30 males, 16 females): 24 child with ALL at 35 day from BFM 95 Protocol and 22 rel apse child with ALL.
Gene regulation by microRNAs (miRNAs) is one of the most important regulatory networks which control normal hematopoiesis. Disturbances in miRNAs levels lead to proliferation diseases including leukemogenesis. MicroRNAs is a major topic of many ca ncer researches performed to discover noninvasive biomarkers used for diagnosis, prognosis, and optimization of clinical decision. This study, the first to be performed in Syria, aimed at monitoring miR-155 levels compared to a normalizer gene RNU6-2 by quantitative reverse transcriptase -PCR (qRTPCR) in a sample of newly diagnosed untreated AML patients at several hospitals in Damascus in comparison with healthy controls. Changes in miR-155 gene expression levels were calculated in patients and controls using the 2-ΔCt method. The most important finding was the association of low and very high miR-155 levels with poor prognosis reflected in failure to accomplish complete remission and high mortality. In addition, high miR-155 levels were associated with M4 AML subtype, although with large variance among patients. We hope our preliminary study pave the road for many future research studies related to the applicability of microRNAs in supporting diagnosis, predicting prognosis, and enhancing the personalized therapies which deal with patients as individual cases.
In contrast to adaptive immunity and to certain components of innate immunity, only little is known on the influence of the complement system on cancer suppression and promotion . The lectin pathway of complement activation is an important part of in nate immunity. It is mainly involved in opsonisation and lysis of pathogens and in recruitment of inflammatory cells. Our study aimed to assess the relationship between MASP-2 serum levels before and after chemotherapy in Syrian children with acute lymphoblastic leukemia, aiming to find a relation, which serve in early forecast of patients response to chemotherapy, where the study has been done at Children University Hospital in damascus between 2013-2014. This study included 37 children diagnosed with acute lymphoblastic leukemia (ALL). The levels of Mannose-Binding Lectin-associated Serine Protease-2 (MASP-2) were determined by Enzyme Linked Immuno Sorbent Assay (ELISA). The result was that serum levels of MASP-2 was strongly reduced after chemotherapy in children with acute lymphoblastic leukemia, and a strong correlation between serum marker levels before and after chemotherapy was found.
Chemotherapy causes neutropenia and increase susceptibility to infections. Morbidity and mortality due to infections remain serious problem in children with cancer. Decreased serum levels of Mannose-binding lectin ( MBL) may represent a risk factor f or infections in children with acute lymphoblastic leukemia receiving chemotherapy. The aim of this study was to determine whether low MBL levels is associated with increased risk of infections in Syrian children with acute lymphoblastic leukemia. The study has been done at Children University Hospital in Damascus between 2013-2014. This study included 37 children diagnosed with acute lymphoblastic leukemia (ALL) who were candidates for chemotherapy, and the infections were identified depending on patients files. The levels of Mannose-Binding Lectin (MBL) was determined by Enzyme Linked Immuno Sorbent Assay (ELISA). The result was that MBL serum levels are higher in patients who did not develop infections compared to patients who developed infections, and all patients with low MBL levels developed infections in contrast to patients with normal MBL serum levels.
Flow cytometry became unavoidable step in the diagnosis of Acute Leukemia . However, accurate diagnosis is conditioned by using proper markers. Objective: to evaluate the quality of performance of four colors protocol, we used for immunophenotyping of acute leukemia in children.
The goal of this research is to study the expression of epidermal and transforming growth factor receptor in normal human bone marrow (BM) cell, and in leukemia ( myeloid and lymphatic leukemia ) which promoted the research for the function of EGF R receptors in the development and growth of BM cells and for malignancies expressing of the EGFR as potential therapeutic targets in blood cell malignant diseases.
mircosoft-partner

هل ترغب بارسال اشعارات عن اخر التحديثات في شمرا-اكاديميا